Small study links prenatal antidepressants to infant brain changes

05/27/2014 | Medscape (free registration)

Infants whose mothers took selective serotonin reuptake inhibitors during pregnancy to treat depression had a higher risk of having Chiari type I brain malformation compared with those not exposed to the drugs, according to a small study in Neuropsychopharmacology. Prenatal exposure to SSRIs was also associated with shorter length, earlier birth and longer stays in neonatal intensive care units.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX